Molecular Partners AG MOLN
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | 0.94% | 17.63% | |||
| Gross Profit | -0.94% | -17.63% | |||
| SG&A Expenses | -1.21% | -9.08% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.30% | 8.18% | |||
| Operating Income | -0.30% | -8.18% | |||
| Income Before Tax | -2.36% | -5.95% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -2.36% | -5.91% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -2.36% | -5.91% | |||
| EBIT | -0.30% | -8.18% | |||
| EBITDA | -0.47% | -6.02% | |||
| EPS Basic | -0.22% | -5.65% | |||
| Normalized Basic EPS | -0.21% | -5.35% | |||
| EPS Diluted | -0.22% | -5.65% | |||
| Normalized Diluted EPS | -0.21% | -5.35% | |||
| Average Basic Shares Outstanding | 2.14% | 0.24% | |||
| Average Diluted Shares Outstanding | 2.14% | 0.24% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||